Although at this time it is not possible to draw firm conclusions as to the pathogenetic role of the GluN2A and GluN2B subunits in human epilepsy, we have to note that clinical observations with positron emission tomography have indicated the significant increase of NMDA receptor ligand binding in human focal epilepsies [96]. This evidence concerns the gene GRIN2A and epilepsy.